Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo

Journal of Gene Medicine

Volumn 4, Issue 6, 2002, Pages 634-643

  Scherer, Franz ^a   Schillinger, Ulrike ^a   Putz, Ursula ^a   Stemberger, Axel ^a   Plank, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Collagen; Gene activated matrix; Luciferase; Nonviral gene vector; Protective copolymer; Subcutaneous implantation

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; BUFFER; CHOLESTEROL; COLLAGEN TYPE 1; COPOLYMER; DRUG CARRIER; LIPOPLEX; LUCIFERASE; NAKED DNA; POLYETHYLENEIMINE; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CELL CULTURE; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; DRUG FORMULATION; DRUG IMPLANTATION; DRUG SYNTHESIS; FREEZE DRYING; GENE EXPRESSION; GENE VECTOR; GENETIC STABILITY; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OPSONIZATION; PRIORITY JOURNAL; PROTECTION; RAT; REPORTER GENE; REPRODUCIBILITY; STANDARD; SUSTAINED DRUG RELEASE; TIME; ANIMAL; CELL STRAIN 3T3; GENE TRANSFER; GENETICS;

EQUIDAE;

3T3 CELLS; ANIMALS; COLLAGEN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LUCIFERASES; MICE; RATS;

EID: 0041768521     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.298     Document Type: Article

References (33)

1. Kunimoto BT. Growth factors in wound healing: the next great innovation? Ostomy Wound Manage 1999; 45: 56-64; quiz 65-66.
2. Erlebacher A, Filvaroff EH, Gitelman SE, et al. Toward a molecular understanding of skeletal development. Cell 1995; 80 371-378.
3. Rosenthal FM, Kohler G. Collagen as matrix for neo-organ formation by gene-transfected fibroblasts. Anticancer Res 1997; 17: 1179-1186.
4. Fang J, Zhu YY, Smiley E, et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A 1996; 93: 5753-5758.
5. Bonadio J, Smiley E, Patil P, et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999; 5: 753-759.
6. Goldstein SA, Bonadio J. Potential role for direct gene transfer in the enhancement of fracture healing. Clin Orthop 1998; S154-162.
7. Kyriakides TR, Hartzel T, Huynh G, et al. Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery. Mol Ther 2001; 3: 842-849.
8. Tyrone JW, Mogford JE, Chandler LA, et al. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J Surg Res 2000; 93: 230-236.
9. Berry M, Gonzalez AM, Clarke W, et al. Sustained effects of gene-activated matrices after CNS injury. Mol Cell Neurosci 2001; 17: 706-716.
10. Pakkanen TM, Laitinen M, Hippelainen M, et al. Periadventitial lacZ gene transfer to pig carotid arteries using a biodegradable collagen collar or a wrap of collagen sheet with adenoviruses and plasmid-liposome complexes. J Gene Med 2000; 2 52-60.
11. Chandler LA, Gu DL, Ma C, et al. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen 2000; 8 473-479.
12. Doukas J, Chandler LA, Gonzalez AM, et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther 2001; 12: 783-798.
13. Finsinger D, Remy JS, Erbacher P, et al. Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther 2000; 7: 1183-1192.
14. Friess W. Collagen - biomaterial for drug delivery. Eur J Pharm Biopharm 1998; 45: 113-136.
15. Stemberger A, Grimm H, Bader F, et al. Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg Suppl 1997; 578: 17-26.
16. Barry ME, Pinto-Gonzalez D, Orson FM, et al. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum Gene Ther 1999; 10: 2461-2480.
17. Crook K, Stevenson BJ, Dubouchet M, et al. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther 1998; 5: 137-143.
18. Rudolph C, Lausier J, Naundorf S, et al. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med 2000; 2: 269-278.
19. Bauer M, Heeg K, Wagner H, et al. DNA activates human immune cells through a CpG sequence-dependent manner. Immunology 1999; 97: 699-705.
20. Klinman DM, Yi AK, Beaucage SL, et al. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A 1996; 93: 2879-2883.
21. Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374 546-549.
22. Yi AK, Klinman DM, Martin TL, et al. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol 1996; 157: 5394-5402.
23. Ogris M, Brunner S, Schuller S, et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
24. Lee JY, Musgrave D, Pelinkovic D, et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001; 83A: 1032-1039.
25. Siemens DR, Austin JC, Hedican SP, et al. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model. J Natl Cancer Inst 2000; 92: 403-412.
26. Jaffee EM, Pardoll DM. Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines. Methods 1997; 12: 143-153.
27. Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999; 68: 830-836; discussion 836-837.
28. Tripathy SK, Black HB, Goldwasser E, et al. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 1996; 2: 545-550.
29. Bonadio J. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv Drug Deliv Rev 2000; 44: 185-194.
30. Cotten M, Wagner E. Non-viral approaches to gene therapy. Curr Opin Biotechnol 1993; 4: 705-710.
31. Han S, Mahato RI, Sung YK, et al. Development of biomaterials for gene therapy. Mol Ther 2000; 2: 302-317.
32. Labhasetwar V, Bonadio J, Goldstein S, et al. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J Pharm Sci 1998; 87: 1347-1350.
33. Shea LD, Smiley E, Bonadio J, et al. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999; 17 551-554.